Weight Loss, Adverse Effects With GLP-1 Medications May Be Influenced by Genetics

This Medical News article discusses findings that genetic variants may affect patients’ responses to glucagon-like peptide-1 receptor agonists such as semaglutide and tirzepatide.

Authors

Publication Details

Journal
JAMA
Published
2026-05-01
DOI
https://doi.org/10.1001/jama.2026.6177
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Weight Loss, Adverse Effects With GLP-1 Medications May Be Influenced by Genetics

Samantha Anderer
JAMA
Diabetes Treatment and Management
article

Weight Loss, Adverse Effects With GLP-1 Medications May Be Influenced by Genetics

Samantha Anderer
article en

Abstract

This Medical News article discusses findings that genetic variants may affect patients’ responses to glucagon-like peptide-1 receptor agonists such as semaglutide and tirzepatide.

JAMA
Openalex Percentile: Top 12%
Diabetes Treatment and Management
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Weight Loss, Adverse Effects With GLP-1 Medications May Be Influenced by Genetics — Samantha Anderer · JAMA (2026) | TGRS Research Map | TGRS